Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 12 | Longs Won 2/8 25% | Profit Factor 1.89 |
| Profitability | Shorts Won 0/4 0% | Standard Deviation $6,024.09 |
| Average Win $11,081.59 | Best Trade (Oct 15) $20,906.38 | Sharpe Ratio -63.59 |
| Average Loss -$1,170.4 | Worst Trade (Aug 11) -$7,021.76 | Z-Score 1.39 (83.47%) |
| Commissions $0 | Avg. Trade Length 1m 1w 6d | Expectancy $887.73 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | 0.02% | 0.18% | 0.8% | 2.6% | 6.79% | 15.29% | 30.89% | 57.42% |
| Consecutive Losing Trades | 95 | 85 | 76 | 66 | 57 | 47 | 38 | 28 | 19 | 9 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
GILD Gilead Sciences Inc. | 705.58 | $91,450.41 | $110,074.23 | - | $18,623.82 | 20.36% | -0.867% |